Reduced vascular endothelial growth factor and capillary density in the occipital cortex in dementia with Lewy bodies.
about
Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson's disease.Accumulation of α-synuclein in dementia with Lewy bodies is associated with decline in the α-synuclein-degrading enzymes kallikrein-6 and calpain-1.Synaptic protein levels altered in vascular dementiaPost-mortem assessment in vascular dementia: advances and aspirations.The neuropathology and cerebrovascular mechanisms of dementiaPathophysiology of Hypoperfusion of the Precuneus in Early Alzheimer's Disease.Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes.The concept of sporadic cerebral small vessel disease: A road map on key definitions and current concepts.Endothelin-converting enzymes degrade α-synuclein and are reduced in dementia with Lewy bodies.Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment.Effect of APOE Genotype on Synaptic Proteins in Earlier Adult Life.White matter hypoperfusion and damage in dementia: post-mortem assessment.The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease.VEGFR1 and VEGFR2 in Alzheimer's Disease.Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.Are Major Dementias Triggered by Poor Blood Flow to the Brain? Theoretical Considerations.Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer's disease and vascular dementia.Differing associations between Aβ accumulation, hypoperfusion, blood-brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease.Investigation of Aβ phosphorylated at serine 8 (pAβ) in Alzheimer's disease, dementia with Lewy bodies and vascular dementia.Long-Term Intravitreal Ranibizumab as a Potential Additional Risk Factor for Neurodegeneration in Parkinson's Disease: A Case Report.
P2860
Q34591096-64275AD9-0AE2-439E-A1B3-5DAEA417CCD0Q34739881-62B270AE-EC5E-4ABF-85B6-AF3172F53DA4Q35753821-86879C31-BC6B-45CC-B47E-960C61E480A3Q36124590-CAA5AD6A-61BB-4F46-8FD2-C9E8EEAE9952Q36593201-77B0E8FC-6654-4C22-ABAB-2582EDAD8B5BQ37169574-D1634445-DA46-4B8A-9D2B-3708446374DDQ38259551-80DD6E0F-D8AA-4EE5-8C33-8C5EB3B61CFFQ38695408-4BC89658-6C7B-450E-BD1B-FBBECFE8A7F2Q38717493-706727EB-D9BD-444A-9D80-B90C420043CDQ40552948-F9B17B0D-C411-4F0B-A16F-1A58753BD6F0Q41273331-B7F26C75-65D4-4D83-9CEC-388698587237Q41674220-DB290E0E-46DE-48BF-A22D-C0624CEB212BQ47257826-55E29F21-94FB-4339-BF35-56F2B2867A53Q47308946-4BF0941E-8624-40BF-8863-1822814715F9Q47770967-52AD93D2-5552-4E8F-AF54-B494EB848659Q48304352-C169B16C-82B0-46C7-BE3E-12498FA56967Q48325111-8BF2891C-1D2E-4B64-A42B-218291468A13Q48328265-C72A6005-A933-4259-A60D-E6733BDFA180Q48392448-89F85D8A-6AA6-4BAF-BD8E-30CAB85B1172Q55317090-5641F314-6EC8-4CDA-AA66-6DA67693D830
P2860
Reduced vascular endothelial growth factor and capillary density in the occipital cortex in dementia with Lewy bodies.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Reduced vascular endothelial g ...... in dementia with Lewy bodies.
@en
Reduced vascular endothelial g ...... in dementia with Lewy bodies.
@nl
type
label
Reduced vascular endothelial g ...... in dementia with Lewy bodies.
@en
Reduced vascular endothelial g ...... in dementia with Lewy bodies.
@nl
prefLabel
Reduced vascular endothelial g ...... in dementia with Lewy bodies.
@en
Reduced vascular endothelial g ...... in dementia with Lewy bodies.
@nl
P2093
P2860
P356
P1433
P1476
Reduced vascular endothelial g ...... in dementia with Lewy bodies.
@en
P2093
Hayley Moulding
Rohan de Silva
Scott Miners
P2860
P304
P356
10.1111/BPA.12130
P577
2014-03-28T00:00:00Z